Exchange: NYSE·Updated 07:30 PM EDT
News
all
press releases
Here's Why Pediatrix Medical Group (MD) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks
More News
Here's Why Pediatrix Medical Can Be a Smart Addition to Your Portfolio
MD's stronger cash collections, favorable payer mix, acquisitions and telehybrid care support its growth prospects.
Zacks
Here's Why Pediatrix Medical Group (MD) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks
Encompass Health Beats Q2 Earnings Estimates, Raises '26 View
EHC beats Q2 earnings estimates as higher patient revenues and strong discharge growth drive results, leading the company to raise its 2026 adjusted EPS outlook.
Zacks
Pediatrix Medical Tops Q2 Earnings on Better Cash Collections
MD posts a Q2 earnings beat as stronger cash collections and a favorable payor mix lift results despite lower volumes.
Zacks
Pediatrix Medical Group (MD) Beats Q2 Earnings and Revenue Estimates
Pediatrix Medical Group (MD) delivered earnings and revenue surprises of +10.53% and +2.19%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Pediatrix Medical Group Reports Second Quarter Results
Pediatrix Medical Group, Inc. (NYSE: MD), a leading provider of physician services, today reported earnings of $0.49 per share for the three months ended June 30, 2026. On a non-GAAP basis, Pediatrix reported Adjusted EPS of $0.63. For the 2026 second quarter, Pediatrix reported the following...
Business Wire
Bausch + Lomb (BLCO) Q2 Earnings Meet Estimates
Bausch + Lomb (BLCO) delivered earnings and revenue surprises of 0.00% and +1.92%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Pediatrix Medical Group (MD) Soars 7.3%: Is Further Upside Left in the Stock?
Pediatrix Medical Group (MD) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Zacks
ELV Beats Q2 Earnings Estimates on Higher CarelonRx Product Revenues
Elevance Health beats Q2 EPS and revenue estimates, raises 2026 adjusted EPS outlook despite lower earnings, softer membership and higher expenses.
Zacks

Advertisement|Remove ads.